Recurrent ovarian cancer: Evidence-based treatment

被引:86
作者
Ozols, RF [1 ]
机构
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
关键词
D O I
10.1200/JCO.2002.20.5.1161
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1161 / 1163
页数:3
相关论文
共 17 条
  • [1] Abu-Rustum N R, 1997, Semin Oncol, V24, pS15
  • [2] Topotecan for the treatment of advanced epithelial ovarian cancer:: An open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel
    Bookman, MA
    Malmström, H
    Bolis, G
    Gordon, A
    Lissoni, A
    Krebs, JB
    Fields, SZ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) : 3345 - 3352
  • [3] Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: Application toward a dynamic disease state model of ovarian cancer
    Dizon, DS
    Hensley, ML
    Poynor, EA
    Sabbatini, P
    Aghajanian, C
    Hummer, A
    Venkatraman, E
    Spriggs, DR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1238 - 1247
  • [4] DUBOIS A, 1999, P AN M AM SOC CLIN, V18, P356
  • [5] TREATMENT OF RELAPSED CARCINOMA OF THE OVARY WITH CISPLATIN OR CARBOPLATIN FOLLOWING INITIAL TREATMENT WITH THESE COMPOUNDS
    GORE, ME
    FRYATT, I
    WILTSHAW, E
    DAWSON, T
    [J]. GYNECOLOGIC ONCOLOGY, 1990, 36 (02) : 207 - 211
  • [6] Cancer statistics, 2001
    Greenlee, RT
    Hill-Harmon, MB
    Murray, T
    Thun, M
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) : 15 - 36
  • [7] PHASE-II STUDY OF GEMCITABINE (2',2'-DIFLUORODEOXYCYTIDINE) IN PREVIOUSLY TREATED OVARIAN-CANCER PATIENTS
    LUND, B
    HANSEN, OP
    THEILADE, K
    HANSEN, M
    NEIJT, JP
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (20) : 1530 - 1533
  • [8] 2ND-LINE PLATINUM THERAPY IN PATIENTS WITH OVARIAN-CANCER PREVIOUSLY TREATED WITH CISPLATIN
    MARKMAN, M
    ROTHMAN, R
    HAKES, T
    REICHMAN, B
    HOSKINS, W
    RUBIN, S
    JONES, W
    ALMADRONES, L
    LEWIS, JL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (03) : 389 - 393
  • [9] Topotecan has substantial antitumor activity as first-line salvage therapy in platinum-sensitive epithelial ovarian carcinoma: A Gynecologic Oncology Group study
    McGuire, WP
    Blessing, JA
    Bookman, MA
    Lentz, SS
    Dunton, CJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (05) : 1062 - 1067
  • [10] Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
    McGuire, WP
    Hoskins, WJ
    Brady, MF
    Kucera, PR
    Partridge, EE
    Look, KY
    ClarkePearson, DL
    Davidson, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (01) : 1 - 6